biblio
“Comprehensive molecular and clinical investigation of approved Anti-HCV drugs repurposing against SARS-CoV-2 infection: a glaring gap between benchside and bedside medicine”, Vaccines, vol. 11, no. 3, p. 515, 2023.
, “Antiviral drugs prioritization for COVID-19 management based on rational selection”, Current Science, vol. 120, no. 9, pp. 1464-1470, 2021.
,